Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

A systematic review of existing medicines has found that antibiotics and vaccinations are associated with a reduced risk of ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Researchers from the universities of Cambridge and Exeter identified several medications - already licensed and in use - with ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

“Most of my new patients come through word of mouth,” says Dr. Boling. Her advice: Look at neighborhood chat groups. Ask friends who their doctors are and why they like them. Have a friend who’s a ...